top of page
News
Feb 3
MitoSense Secures Japanese Patent for Groundbreaking Mitochondria-Based Therapy for Neurodegenerative Diseases
February 4, 2025 – Plymouth, MA – MitoSense Inc., a pioneering biotechnology company specializing in mitochondria-based therapeutics, is...
Dec 2, 2024
MitoSense, Inc. Secures U.S. Patent for Innovative Treatment of Neurodegenerative Diseases
Plymouth, MA, Dec 2, 2024 – MitoSense, Inc., a pioneering research and development company focused on treatments for neurodegenerative...
Nov 12, 2024
MitoSense Inc. Publishes Breakthrough Study on Cryopreserved Fibroblast and Mesenchymal Stem Cells as Alternative Mitochondrial Donors
Plymouth, MA – November 12, 2024 – MitoSense Inc., a leader in mitochondria lresearch and innovation, proudly announces the publication...
Sep 6, 2024
MitoSense Applauds Elliott Mitochondria Research Center's Benefit Concert: A Night to END ALS & TBI
September 6, 2024 – Tampa, FL  – MitoSense, holder of an exclusive license on groundbreaking technology from the Elliott Mitochondria...
bottom of page